EUVIMEDEUVIMED entdecken
Crossref

L26/P-756 Impact of dyslipidemia on cumulative live birth rate in PCOS patients undergoing IVF/ICSI and a predictive nomogram

X. Chen, H. Xu, B. Zheng

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von X. Chen und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can a predictive model for cumulative live birth rate (CLBR) be developed based on dyslipidemia status in PCOS patients undergoing their first IVF/ICSI cycle? Summary answer Elevated triglycerides (TG) independently reduced CLBR, and a nomogram based on BMI, TG, high-quality blastocyst rate, and high-quality embryo rate acceptably predicts it. What is known already Obesity, insulin resistance, and dyslipidemia impact pregnancy. Management in PCOS focuses on weight and insulin resistance, with lipid management receiving less attention. While dyslipidemia’s effect on live birth per cycle has been studied, its impact on CLBR in PCOS patients undergoing IVF/ICSI is not well-established. Study design, size, duration A retrospective cohort study of 413 PCOS patients (<40 years) undergoing their first IVF/ICSI cycle (long or antagonist protocol) between January 2022 and May 2024. Participants/materials, setting, methods Patients were categorized into dyslipidemic (n = 277) and normolipidemic (n = 136) groups. Groups were compared, and stratified analyses by Body mass index (BMI) and homeostatic model assessment-insulin resistance (HOMA-IR) were performed. Logistic regression identified CLBR predictors. A nomogram was built and validated using training and validation sets, with internal validation performed via Bootstrap resampling (1000 iterations). Main results and the role of chance Elevated TG was an independent risk factor for reduced CLBR (adjusted odds ratio=0.732, 95% confidence interval: 0.552-0.969, P = 0.029). The predictive model included BMI, TG, high-quality blastocyst rate, and high-quality embryo rate. It demonstrated moderate discrimination with an area under the curve (AUC) of 0.776 (95% CI 0.709–0.843) in the training set and 0.721 (95% CI 0.601–0.840) upon internal validation. Calibration and decision curve analysis indicated good consistency and clinical utility. Limitations, reasons for caution This single-center retrospective study may have selection bias. The model did not account for potential confounders like diet or exercise, and assessed only baseline (not dynamic) lipid levels. The validation set sample size (n = 123) is relatively small. Wider implications of the findings The model helps identify patients at potentially low CLBR, enabling personalized pre-transfer strategies targeting modifiable factors like weight and lipid control. This optimizes the treatment pathway and supports targeted counseling in PCOS patients with dyslipidemia undergoing IVF/ICSI. Trial registration number No

Zitieren

APA

Chen, X., Xu, H., & Zheng, B. (2026). L26/P-756 Impact of dyslipidemia on cumulative live birth rate in PCOS patients undergoing IVF/ICSI and a predictive nomogram. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1083

Vancouver

Chen X, Xu H, Zheng B. L26/P-756 Impact of dyslipidemia on cumulative live birth rate in PCOS patients undergoing IVF/ICSI and a predictive nomogram. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1083

BibTeX
@article{Chen2026,
  author = {Chen, X. and Xu, H. and Zheng, B.},
  title = {L26/P-756 Impact of dyslipidemia on cumulative live birth rate in PCOS patients undergoing IVF/ICSI and a predictive nomogram},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1083}
}
Kostenlos starten →